Acne Vulgaris – 1997

[Systemic treatment of acne with isotretinoin: current status].
Plewig G, Albrecht G, Henz BM, Meigel W, Schöpf E, Stadler R.
Hautarzt. 1997 Dec;48(12):881-5. Review. German.

Acne vulgaris: a treatment update.
Usatine RP, Quan MA, Strick R.
Hosp Pract (Minneap). 1998 Feb 15;33(2):111-7, 121-4, 127. Review.

Antibiotic resistance can be an unwelcome side-effect of acne treatment.
Dawson J.
Lancet. 1998 Feb 7;351(9100):422.

Comparative evaluation of topical benzoyl peroxide, metronidazole and benzoyl peroxide – clindamycin combination in treatment of acne vulgaris.
Jain VK, Chopra KL, Dayal S.
Indian J Dermatol Venereol Leprol. 1998 Mar-Apr;64(2):71-4.

Treatment of androgen excess in females: yesterday, today and tomorrow.
Pucci E, Petraglia F.
Gynecol Endocrinol. 1997 Dec;11(6):411-33. Review.

[Allergy to benzoyl peroxide in an anti-acne gel].
Villas Martínez F, Joral A, Garmendia FJ.
Aten Primaria. 1997 Oct 31;20(7):397-8. Spanish.

Isotretinoin: which dosage?
Cooper AJ.
Australas J Dermatol. 1997 Nov;38(4):183-4. Review.

Roaccutane and wax epilation: a cautionary tale.
Woollons A, Price ML.
Br J Dermatol. 1997 Nov;137(5):839-40.

Characteristics of adolescent patients and their health problems at an adolescent health clinic.
Lee MC, Liao CF, Lee SH, Lu TH, Chou MC.
Kaohsiung J Med Sci. 1997 Sep;13(9):548-55.

Paper in BMJ influenced prescribing of minocycline.
Ferguson JJ, Jenkins MG, Field J.
BMJ. 1998 Jan 3;316(7124):72-3.

Post-adolescent acne and marital break-up.
Harrington CI.
Br J Dermatol. 1997 Sep;137(3):478-9.

The sulfone syndrome complicated by pancreatitis and pleural effusion in an adolescent receiving dapsone for treatment of acne vulgaris.
Corp CC, Ghishan FK.
J Pediatr Gastroenterol Nutr. 1998 Jan;26(1):103-5.

Current options for the topical treatment of acne vulgaris.
Weiss JS.
Pediatr Dermatol. 1997 Nov-Dec;14(6):480-8. Review.

Two cases of musculoskeletal syndrome associated with acne.
Erhardt E, Harangi F.
Pediatr Dermatol. 1997 Nov-Dec;14(6):456-9.

Acne fulminans and bone lesions may present to other specialties.
Gordon PM, Farr PM, Milligan A.
Pediatr Dermatol. 1997 Nov-Dec;14(6):446-8.

Ethical and legal aspects of teratogenic medications: the case of isotretinoin.
Moskop JC, Smith ML, De Ville K.
J Clin Ethics. 1997 Fall;8(3):264-78. Review.

Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
Higaki S, Morimatsu S, Morohashi M, Yamagishi T, Hasegawa Y.
J Int Med Res. 1997 Nov-Dec;25(6):318-24.

Effects of isotretinoin therapy on lipoprotein (a) serum levels.
Georgala S, Schulpis KH, Potouridou I, Papadogeorgaki H.
Int J Dermatol. 1997 Nov;36(11):863-4.

Variations in lipid and lipoprotein levels during isotretinoin treatment for acne vulgaris with special emphasis on HDL-cholesterol.
Lestringant GG, Frossard PM, Agarwal M, Galadari IH.
Int J Dermatol. 1997 Nov;36(11):859-62.

Testosterone concentrations and oligomenorrhea in women with acne.
Hasinski S, Telang GH, Rose LI, Pollock JL, Spielvogel RL, Miller JL.
Int J Dermatol. 1997 Nov;36(11):845-7.

Polarized light photography enhances visualization of inflammatory lesions of acne vulgaris.
Phillips SB, Kollias N, Gillies R, Muccini JA, Drake LA.
J Am Acad Dermatol. 1997 Dec;37(6):948-52.

Acne in Victorian adolescents: associations with age, gender, puberty and psychiatric symptoms.
Kilkenny M, Stathakis V, Hibbert ME, Patton G, Caust J, Bowes G.
J Paediatr Child Health. 1997 Oct;33(5):430-3.

Acne. What every pediatrician should know about treatment.
Strasburger VC.
Pediatr Clin North Am. 1997 Dec;44(6):1505-23. Review.

Renal amyloidosis and renal failure–a novel complication of the SAPHO syndrome.
Valentin R, Gürtler KF, Schaker A.
Nephrol Dial Transplant. 1997 Nov;12(11):2420-3.

Azelaic acid 20% cream (AZELEX) and the medical management of acne vulgaris.
Gibson JR.
Dermatol Nurs. 1997 Oct;9(5):339-44. Review.

The effectiveness of acne treatment: an assessment by patients of the outcome of therapy.
Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY.
Br J Dermatol. 1997 Oct;137(4):563-7.

Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris.
Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ.
J Am Acad Dermatol. 1997 Nov;37(5 Pt 1):746-54.

Effect of keigai-rengyo-to, a Japanese kampo medicine, on neutrophil functions: a possible mechanism of action of keigai-rengyo-to in acne.
Akamatsu H, Asada Y, Horio T.
J Int Med Res. 1997 Sep-Oct;25(5):255-65.

Gonadotropin-releasing hormone agonists administration in polycystic ovary syndrome. Effects on bone mass.
Lupoli G, Di Carlo C, Nuzzo V, Vitale G, Russo D, Palomba S, Nappi C.
J Endocrinol Invest. 1997 Sep;20(8):493-6.

Resurfacing of pitted facial scars with a pulsed Er:YAG laser.
Kye YC.
Dermatol Surg. 1997 Oct;23(10):880-3.

Dermabrasion. Is it an option?
Smith R.
Aust Fam Physician. 1997 Sep;26(9):1041-4. Review.

Spread of antibiotic-resistant bacteria from acne patients to personal contacts–a problem beyond the skin?
Bolognia JL, Edelson RL.
Lancet. 1997 Oct 4;350(9083):972-3.

Topical delivery system for tretinoin: research and clinical implications.
Skov MJ, Quigley JW, Bucks DA.
J Pharm Sci. 1997 Oct;86(10):1138-43.

Reliability of acne lesion counting.
Shalita AR, Leyden JJ Jr, Kligman AM.
J Am Acad Dermatol. 1997 Oct;37(4):672.

Treatment of acne with a combination clindamycin/benzoyl peroxide gel compared with clindamycin gel, benzoyl peroxide gel and vehicle gel: combined results of two double-blind investigations.
Lookingbill DP, Chalker DK, Lindholm JS, Katz HI, Kempers SE, Huerter CJ, Swinehart JM, Schelling DJ, Klauda HC.
J Am Acad Dermatol. 1997 Oct;37(4):590-5.

Prevalence of acne keloidalis nuchae in football players.
Knable AL Jr, Hanke CW, Gonin R.
J Am Acad Dermatol. 1997 Oct;37(4):570-4.

Treatment of scars: a review.
Alster TS, West TB.
Ann Plast Surg. 1997 Oct;39(4):418-32. Review.

Topical retinoid introduced for plaque psoriasis, acne vulgaris.
[No authors listed]
Am J Health Syst Pharm. 1997 Sep 15;54(18):2037.

Histological and clinical evaluation of facial resurfacing using a carbon dioxide laser with the computer pattern generator.
Rubach BW, Schoenrock LD.
Arch Otolaryngol Head Neck Surg. 1997 Sep;123(9):929-34.

Age at menarche in Thai girls.
Chompootaweep S, Tankeyoon M, Poomsuwan P, Yamarat K, Dusitsin N.
Ann Hum Biol. 1997 Sep-Oct;24(5):427-33.

Isotretinoin, tetracycline and circulating hormones in acne.
Palatsi R, Ruokonen A, Oikarinen A.
Acta Derm Venereol. 1997 Sep;77(5):394-6.

[Side effects of minocycline in the treatment of acne vulgaris. Dutch Society of Family Physicians].
van der Laan J.
Ned Tijdschr Geneeskd. 1997 Aug 30;141(35):1708-9. Dutch.

[Treatment of acne].
Fyrand O.
Tidsskr Nor Laegeforen. 1997 Aug 30;117(20):2985-7. Norwegian.

[Dermatology in practice–practical dermatology].
Jensen P.
Tidsskr Nor Laegeforen. 1997 Aug 30;117(20):2933. Norwegian.

Advances and perspectives in acne therapy.
Jansen T, Plewig G.
Eur J Med Res. 1997 Aug 28;2(8):321-34. Review.

Steroid 5alpha-reductase inhibitors in androgen-dependent disorders.
Harris GS, Kozarich JW.
Curr Opin Chem Biol. 1997 Aug;1(2):254-9. Review.

Topical sodium sulfacetamide/sulfur lotion.
Tarimci N, Sener S, Kilinç T.
J Clin Pharm Ther. 1997 Aug;22(4):301.

Early predictors of severity of acne vulgaris.
Aggarwal V.
Indian Pediatr. 1997 Aug;34(8):751-2.

[Neonatal acne or newborn follicular pityriasis ].
Piérard GE, Piérard-Franchimont C.
Rev Med Liege. 1997 Aug;52(8):505. French.

Descriptive epidemiology of acne vulgaris in the community.
Stathakis V, Kilkenny M, Marks R.
Australas J Dermatol. 1997 Aug;38(3):115-23. Review.

Suicide in dermatological patients.
Cotterill JA, Cunliffe WJ.
Br J Dermatol. 1997 Aug;137(2):246-50.

Photosensitivity due to doxycycline hydrochloride with an unusual flare.
Tanaka N, Kawada A, Ohnishi Y, Hiruma M, Tajima S, Akiyama M, Ishibashi A.
Contact Dermatitis. 1997 Aug;37(2):93-4.

Dispelling myths about acne.
Landow K.
Postgrad Med. 1997 Aug;102(2):94-9, 103-4, 110-2. Review.

Percutaneous absorption of salicylic acid after repeated (14-day) in vivo administration to normal, acnegenic or aged human skin.
Davis DA, Kraus AL, Thompson GA, Olerich M, Odio MR.
J Pharm Sci. 1997 Aug;86(8):896-9.

[Side effects of minocycline in the treatment of acne vulgaris].
Hoefnagel JJ, van Leeuwen RL, Mattie H, Bastiaens MT.
Ned Tijdschr Geneeskd. 1997 Jul 19;141(29):1424-7. Review. Dutch.

Intracranial hypertension and minocycline.
Shiri J, Amichai B.
Ann Intern Med. 1997 Jul 15;127(2):168.

Treatment of acne with intermittent isotretinoin.
Goulden V, Clark SM, McGeown C, Cunliffe WJ.
Br J Dermatol. 1997 Jul;137(1):106-8.

Acne.
Munro CS.
J R Coll Physicians Lond. 1997 Jul-Aug;31(4):360-3. Review.

Urethritis associated with isotretinoin therapy.
Edwards S, Sonnex C.
Acta Derm Venereol. 1997 Jul;77(4):330.

Minocycline induces an increase in the number of excreting pilosebaceous follicles in acne vulgaris. A randomised study.
Bodokh I, Jacomet Y, Lacour JP, Ortonne JP.
Acta Derm Venereol. 1997 Jul;77(4):255-9.

Acne lesion counts and global assessments.
Rand S.
J Am Acad Dermatol. 1997 Jul;37(1):138.

Development and validation of a quality of life instrument for cutaneous diseases.
Anderson RT, Rajagopalan R.
J Am Acad Dermatol. 1997 Jul;37(1):41-50.

A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome.
Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT.
Mayo Clin Proc. 1997 Jul;72(7):611-5.

Androgen-receptor blockade does not impair bone mineral density in adolescent females.
Bertelloni S, Baroncelli GI, Sorrentino MC, Costa S, Battini R, Saggese G.
Calcif Tissue Int. 1997 Jul;61(1):1-5.

[Pathogenesis and diagnosis of androgenetic manifestations].
Imthurn B.
Praxis (Bern 1994). 1997 Jun 4;86(23):993-5. Review. German.

Current concepts of polycystic ovary syndrome.
Rosenfield RL.
Baillieres Clin Obstet Gynaecol. 1997 Jun;11(2):307-33. Review.

A comparison of current acne grading systems and proposal of a novel system.
Doshi A, Zaheer A, Stiller MJ.
Int J Dermatol. 1997 Jun;36(6):416-8.

Clinical efficacy and safety comparison of adapalene gel and tretinoin gel in the treatment of acne vulgaris: Europe and U.S. multicenter trials.
Cunliffe WJ, Caputo R, Dreno B, Förström L, Heenen M, Orfanos CE, Privat Y, Robledo Aguilar A, Meynadier J, Alirezai M, Jablonska S, Shalita A, Weiss JS, Chalker DK, Ellis CN, Greenspan A, Katz HI, Kantor I, Millikan LE, Swinehart JM, Swinyer L, Whitmore C, Czernielewski J, Verschoore M.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S126-34.

Skin distribution and pharmaceutical aspects of adapalene gel.
Allec J, Chatelus A, Wagner N.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S119-25.

Adapalene 0.1% gel is better tolerated than tretinoin 0.025% gel in acne patients.
Clucas A, Verschoore M, Sorba V, Poncet M, Baker M, Czernielewski J.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S116-8.

Skin tolerance of adapalene 0.1% gel in combination with other topical antiacne treatments.
Caron D, Sorba V, Clucas A, Verschoore M.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S113-5.

Split-face comparison of adapalene 0.1% gel and tretinoin 0.025% gel in acne patients.
Caron D, Sorba V, Kerrouche N, Clucas A.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S110-2.

Adapalene 0.1% gel has low skin-irritation potential.
Verschoore M, Poncet M, Czernielewski J, Sorba V, Clucas A.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S104-9.

The treatment of acne with topical retinoids: one man’s opinions.
Kligman AM.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 2):S92-5.

Acne inversa (pyodermia fistulans sinifica) and smoking.
Bassukas ID, Hundeiker M.
J Am Acad Dermatol. 1997 Jun;36(6 Pt 1):1029.

Ultrapulse carbon dioxide laser with CPG scanner for full-face resurfacing for rhytids, photoaging, and acne scars.
Apfelberg DB.
Plast Reconstr Surg. 1997 Jun;99(7):1817-25.

Know how. Treatment of acne.
Poyner T.
Nurs Times. 1997 May 28-Jun 3;93(22):20-1.

Acne: avoiding permanent damage.
Boston M.
Community Nurse. 1997 May;3(4):15-6. Review.

[Fatty acids and the epidermis].
Schneider IM, Wohlrab W, Neubert R.
Hautarzt. 1997 May;48(5):303-10. Review. German.

Juvenile nodulocystic acne responding to systemic isotretinoin.
Horne HL, Carmichael AJ.
Br J Dermatol. 1997 May;136(5):796-7. Review.

IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
Ashbee HR, Muir SR, Cunliffe WJ, Ingham E.
Br J Dermatol. 1997 May;136(5):730-3.

Subcorneal pustular dermatosis (Sneddon-Wilkinson syndrome): another cutaneous manifestation of SAPHO syndrome?
Scarpa R, Lubrano E, Cozzi R, Ames PR, Oriente CB, Oriente P.
Br J Rheumatol. 1997 May;36(5):602-3.

Psoriatic arthritis and minocycline induced autoantibodies.
Leitch DN, Haslock DI.
Clin Rheumatol. 1997 May;16(3):317-8.

Study of immune reactivity of minocycline-induced chronic active hepatitis.
Herzog D, Hajoui O, Russo P, Alvarez F.
Dig Dis Sci. 1997 May;42(5):1100-3.

Clinical resistance to erythromycin and clindamycin in cutaneous propionibacteria isolated from acne patients is associated with mutations in 23S rRNA.
Ross JI, Eady EA, Cove JH, Jones CE, Ratyal AH, Miller YW, Vyakrnam S, Cunliffe WJ.
Antimicrob Agents Chemother. 1997 May;41(5):1162-5.

Benefit-risk assessment of acne therapies.
Bénéton N, Bocquet H, Cosnes A, Revuz J, Roujeau JC.
Lancet. 1997 Apr 26;349(9060):1252.

Benefit-risk assessment of acne therapies.
Seukeran DC, Eady EA, Cunliffe WJ.
Lancet. 1997 Apr 26;349(9060):1251-2.

[SAPHO syndrome: common denominator for various bone and skin diseases].
Jahangier ZN, Jacobs JW, Bijlsma JW.
Ned Tijdschr Geneeskd. 1997 Apr 19;141(16):764-9. Review. Dutch.

Therapy for acne vulgaris.
Leyden JJ.
N Engl J Med. 1997 Apr 17;336(16):1156-62. Review.

Diagnosing streptococcal pharyngitis in patients taking antibiotics.
Brunell P.
JAMA. 1997 Apr 16;277(15):1197.

[Emryopathy due to isotretinoine. A case history of one observation].
Balliu Badía PR, Saus Sarrias C, Pérez Ferrón JJ, Alomar Ribas A, Mir Montes G.
An Esp Pediatr. 1997 Apr;46(4):397-8. Spanish.

Current management of acne.
O’Loughlin S.
Ir Med J. 1997 Apr-May;90(3):92-3.

[The SAPHO syndrome and ulcerative colitis].
Sanjuán Portugal F, Nerín Sánchez C, Fuentes Solsona F, Rubín de Celis C.
An Med Interna. 1997 Apr;14(4):210-1. Review. Spanish.

Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
Timpatanapong P, Rojanasakul A.
J Dermatol. 1997 Apr;24(4):223-9.

Aesthetic skin resurfacing with the high-energy ultrapulsed CO2 laser.
Weinstein C, Roberts TL 3rd.
Clin Plast Surg. 1997 Apr;24(2):379-405. Review.

Therapeutic skin care in the mature patient.
Draelos ZD.
Clin Plast Surg. 1997 Apr;24(2):369-77. Review.

Norgestimate and ethinyl estradiol in the treatment of acne vulgaris: a randomized, placebo-controlled trial.
Redmond GP, Olson WH, Lippman JS, Kafrissen ME, Jones TM, Jorizzo JL.
Obstet Gynecol. 1997 Apr;89(4):615-22.

Advances in the acupuncture treatment of acne.
Dai G.
J Tradit Chin Med. 1997 Mar;17(1):65-72. Review.

Saving face. Treating adolescents affected by acne vulgaris.
Peters S.
Adv Nurse Pract. 1997 Mar;5(3):43-6, 49, 64. Review.

Comparison of serum antibiotic levels in acne patients receiving the standard or a modified release formulation of minocycline hydrochloride.
Gardner KJ, Eady EA, Cove JH, Taylor JP, Cunliffe WJ.
Clin Exp Dermatol. 1997 Mar;22(2):72-6.

[SAPHO syndrome. Case description of 3 patients with acne conglobata and osteoarticular symptoms].
Gutzmer R, Herbst RA, Kapp A, Weiss J.
Hautarzt. 1997 Mar;48(3):186-90. German.

Acne vulgaris.
Galen BA.
Lippincotts Prim Care Pract. 1997 Mar-Apr;1(1):88-92. Review.

Acne treatment. A comprehensive review of pharmacotherapy.
Taffe AM.
Lippincotts Prim Care Pract. 1997 Mar-Apr;1(1):70-87. Review.

Azithromycin for the treatment of acne.
Fernandez-Obregon AC.
Int J Dermatol. 1997 Mar;36(3):239-40.

5 alpha-reductase inhibitors–a new hope in dermatology?
Amichai B, Grunwald MH, Sobel R.
Int J Dermatol. 1997 Mar;36(3):182-4. Review.

Gym and tonic: a profile of 100 male steroid users.
Evans NA.
Br J Sports Med. 1997 Mar;31(1):54-8.

Acne conglobata and Klinefelter’s syndrome.
Wollenberg A, Wolff H, Jansen T, Schmid MH, Röcken M, Plewig G.
Br J Dermatol. 1997 Mar;136(3):421-3.

Light and electron microscopic findings in human epidermis reconstructed in vitro upon topical application of liposomal tretinoin.
Schaller M, Steinle R, Korting HC.
Acta Derm Venereol. 1997 Mar;77(2):122-6.

Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne.
Brogden RN, Goa KE.
Drugs. 1997 Mar;53(3):511-9. Review.

An extremely effective treatment for serious inflammatory acne: an uncontrolled, unblinded, unstatistical office study.
Kligman AM.
Cutis. 1997 Mar;59(3):109-10.

Sebaceous gland, acne and related disorders–basic and clinical research, clinical entities and treatment. IV International Dermatology Symposium. Berlin, Germany, April 11-13, 1997. Abstracts.
[No authors listed]
J Invest Dermatol. 1997 Mar;108(3):371-98.

Adapalene for acne.
[No authors listed]
Med Lett Drugs Ther. 1997 Feb 28;39(995):19-20.

[Gram negative folliculitis. A complication of antibiotic therapy of acne vulgaris. 2: Diagnosis and differential diagnosis–therapy].
Jansen T, Plewig G.
Fortschr Med. 1997 Feb 10;115(4):42-4. German.

Minocycline-induced oral hyperpigmentation.
Eisen D.
Lancet. 1997 Feb 8;349(9049):400.

Safety of minocycline for acne.
Gottlieb A.
Lancet. 1997 Feb 8;349(9049):374.

Acne Vulgaris.
Rabinowitz LG.
Adolesc Med. 1997 Feb;8(1):77-86.

[Sex steroid-binding globulin, free serum testosterone, and androgen receptors in the skin during papulo-pustulosa and conglobate forms of acne vulgaris].
Kushlinskii NE, Salamova IV, Masiukova SA, Mukhammad AKh, Degtiar’ VG, Samsonov VA.
Biull Eksp Biol Med. 1997 Feb;123(2):188-91. Russian.

[Pharma Clinics. Drug of the month. Benzamycin, an up-date on topical treatment of acne].
Piérard GE.
Rev Med Liege. 1997 Feb;52(2):120-2. Review. French.

Laser-assisted dermal grafting for the correction of cutaneous contour defects.
Goodman G.
Dermatol Surg. 1997 Feb;23(2):95-9.

Isotretinoin-induced vasculitis imitating polyarteritis nodosa, with perinuclear antineutrophil cytoplasmic antibody in titers correlated with clinical symptoms.
Chochrad D, Langhendries JP, Stolear JC, Godin J.
Rev Rhum Engl Ed. 1997 Feb;64(2):129-31.

The comparative efficacy of benzoyl peroxide 5%/erythromycin 3% gel and erythromycin 4%/zinc 1.2% solution in the treatment of acne vulgaris.
Chu A, Huber FJ, Plott RT.
Br J Dermatol. 1997 Feb;136(2):235-8.

Dermatology quality of life scales–a measure of the impact of skin diseases.
Morgan M, McCreedy R, Simpson J, Hay RJ.
Br J Dermatol. 1997 Feb;136(2):202-6.

Activity of type 1 5 alpha-reductase is greater in the follicular infrainfundibulum compared with the epidermis.
Thiboutot DM, Knaggs H, Gilliland K, Hagari S.
Br J Dermatol. 1997 Feb;136(2):166-71.

The changes of stratum corneum interstices and calcium distribution of follicular epithelium of experimentally induced comedones (EIC) by oleic acid.
Choi EH, Ahn SK, Lee SH.
Exp Dermatol. 1997 Feb;6(1):29-35.

A critical appraisal of high-energy pulsed carbon dioxide laser facial resurfacing for acne scars.
Apfelberg DB.
Ann Plast Surg. 1997 Feb;38(2):95-100.

Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients.
Cicardi M, Castelli R, Zingale LC, Agostoni A.
J Allergy Clin Immunol. 1997 Feb;99(2):194-6.

How to ensure fetal safety when mothers use isotretinoin (Accutane).
Koren G, Pastuszak A.
Can Fam Physician. 1997 Feb;43:216-9. Review.

Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline.
MacNeil M, Haase DA, Tremaine R, Marrie TJ.
J Am Acad Dermatol. 1997 Feb;36(2 Pt 2):347-50.

Cosmetic surgery with lasers.
[No authors listed]
Med Lett Drugs Ther. 1997 Jan 31;39(993):10-1.

[Gram-negative folliculitis. Complication of antibiotic therapy of acne vulgaris, 1: Disease picture and classification–special form: whirlpool dermatitis].
Jansen T, Plewig G.
Fortschr Med. 1997 Jan 30;115(3):37-8. German.

Griseofulvin therapy in acne vulgaris.
Dayal S, Jain VK.
Indian J Dermatol Venereol Leprol. 1997 Jan-Feb;63(1):70-1.

[Diffusion of minocycline in comedons of patients with acne vulgaris].
Chosidow O, Poli F, Naline E, Advenier C, Revuz J.
Ann Dermatol Venereol. 1997;124(10):726-7. French.

[Acne, hyperandrogenism and oral isotretinoin resistance. 23 cases. Therapeutic implications].
Lehucher-Ceyrac D, Chaspoux C, Weber MJ, Morel P, Vexiau P.
Ann Dermatol Venereol. 1997;124(10):692-5. French.

[Gilbert disease and isotretinoin].
Le Gal FA, Pauwels C.
Ann Dermatol Venereol. 1997;124(6-7):463-6. French.

Aseptic spondylitis as the initial manifestation of the SAPHO syndrome.
Kotilainen P, Gullichsen RE, Saario R, Manner I, Kotilainen E.
Eur Spine J. 1997;6(5):327-9.

Acne fulminans and erythema nodosum during isotretinoin therapy responding to dapsone.
Tan BB, Lear JT, Smith AG.
Clin Exp Dermatol. 1997 Jan;22(1):26-7.

Oral isotretinoin treatment policy. Do we all agree?
Ortonne JP.
Dermatology. 1997;195 Suppl 1:34-7; discussion 38-40. Review.

Oral isotretinoin. How can we treat difficult acne patients?
Leyden JJ.
Dermatology. 1997;195 Suppl 1:29-33; discussion 38-40. Review.

How safe is oral isotretinoin?
Meigel WN.
Dermatology. 1997;195 Suppl 1:22-8; discussion 38-40. Review.

Scarred for life?
Layton AM, Seukeran D, Cunliffe WJ.
Dermatology. 1997;195 Suppl 1:15-21; discussion 38-40.

How cost-effective is oral isotretinoin?
Newton JN.
Dermatology. 1997;195 Suppl 1:10-4; discussion 38-40. Review.

Does oral isotretinoin prevent Propionibacterium acnes resistance?
Coates P, Adams CA, Cunliffe WJ, McGinley KT, Eady EA, Leyden JJ, Ravenscroft J, Vyakrnam S, Vowels B.
Dermatology. 1997;195 Suppl 1:4-9; discussion 38-40. Review.

Oral isotretinoin. Where now, where next?
Saurat JH.
Dermatology. 1997;195 Suppl 1:1-3; discussion 38-40. Review.

Peculiar distribution of comedones: a report of three cases.
del Río E.
Dermatology. 1997;195(2):162-3.

Roaccutane treatment guidelines: results of an international survey.
Cunliffe WJ, van de Kerkhof PC, Caputo R, Cavicchini S, Cooper A, Fyrand OL, Gollnick H, Layton AM, Leyden JJ, Mascaró JM, Ortonne JP, Shalita A.
Dermatology. 1997;194(4):351-7.

Sebum excretion in hidradenitis suppurativa.
Jemec GB, Gniadecka M.
Dermatology. 1997;194(4):325-8.

Phototherapy of acne vulgaris with visible light.
Sigurdsson V, Knulst AC, van Weelden H.
Dermatology. 1997;194(3):256-60.

Acquired hyperostosis syndrome–AHYS–(sternocostoclavicular hyperostosis, pustulotic arthro-osteitis, SAPHO-syndrome): bone scintigraphy of the anterior chest wall.
Dihlmann W, Dihlmann SW, Hering L.
Clin Rheumatol. 1997 Jan;16(1):13-24.

The effect of glycolic acid on the treatment of acne in Asian skin.
Wang CM, Huang CL, Hu CT, Chan HL.
Dermatol Surg. 1997 Jan;23(1):23-9.

Acute arthritis during isotretinoin treatment for acne conglobata.
De Francesco V, Stinco G, Campanella M.
Dermatology. 1997;194(2):195.

[Multifocal periostitis in the SAPHO syndrome in Fortschr. Röntgenstr. 164 (1996) 514-516 (Case Reports)].
Schilling F.
Rofo. 1997 Jan;166(1):90-1; author reply 92-3. German.

[Why SAPHO? Why adequate scintigraphy in this syndrome? Comments on M. Steinberg et al.: Multifocal periostitis in the SAPHO syndrome. Fortschr. Röntgenstr. 164 (1996) 514-516].
Dihlmann W.
Rofo. 1997 Jan;166(1):87-9; author reply 92-3. German.

Pseudotumor cerebri induced by minocycline treatment for acne vulgaris.
Lewis PA, Kearney PJ.
Acta Derm Venereol. 1997 Jan;77(1):83.

Effects of dermabrasion on acne scarring. A review and a study of 25 cases.
Aronsson A, Eriksson T, Jacobsson S, Salemark L.
Acta Derm Venereol. 1997 Jan;77(1):39-42.

Spondylodiscitis in SAPHO syndrome. A series of eight cases.
Toussirot E, Dupond JL, Wendling D.
Ann Rheum Dis. 1997 Jan;56(1):52-8.

Acne fulminans treated with isotretinoin and “pulse” corticosteroids.
Allison MA, Dunn CL, Person DA.
Pediatr Dermatol. 1997 Jan-Feb;14(1):39-42.

Ectrodactyly, soft-tissue syndactyly, and nodulocystic acne: coincidence or association?
Krunic AL, Vesic SA, Goldner B, Novak A, Clark RE.
Pediatr Dermatol. 1997 Jan-Feb;14(1):31-5.

Pathogenesis and treatment of acne in childhood.
Jansen T, Burgdorf WH, Plewig G.
Pediatr Dermatol. 1997 Jan-Feb;14(1):17-21.

Post-adolescent acne: a review of clinical features.
Goulden V, Clark SM, Cunliffe WJ.
Br J Dermatol. 1997 Jan;136(1):66-70.

Psychodermatology of women.
Koblenzer CS.
Clin Dermatol. 1997 Jan-Feb;15(1):127-41. Review.

Minocycline-induced intraoral pharmacogenic pigmentation: case reports and review of the literature.
Westbury LW, Najera A.
J Periodontol. 1997 Jan;68(1):84-91. Review.

Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study.
Lucky AW, Biro FM, Simbartl LA, Morrison JA, Sorg NW.
J Pediatr. 1997 Jan;130(1):30-9.

“Awaiting an eruption”: predictors of acne vulgaris.
Hansen RC.
J Pediatr. 1997 Jan;130(1):5.

Acne. An overview of clinical research findings.
Thiboutot DM.
Dermatol Clin. 1997 Jan;15(1):97-109. Review.

Acute hepatitis and drug-related lupus induced by minocycline treatment.
Golstein PE, Deviere J, Cremer M.
Am J Gastroenterol. 1997 Jan;92(1):143-6.